Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Adial Pharmaceuticals Inc logo

Adial Pharmaceuticals Inc

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 9 M  90-day average vol: 6,463,994

Previous close: 2.24  Open: 2.24  Bid: 2.25  Ask: 2.33
52 week range    
Last updated: Thursday 18th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


ADIL Income Statement

Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-563.0-565.0248971.0
Basic EPS from continuing operations-0.51
Basic EPS total-1.04-0.51
Basic weighted shares outstanding5 M10 M12 M19 M25 M
Cost of sales-40000.0-40000.0550000.0
Diluted EPS total-2.44-0.87-0.87-1.05-0.51
Diluted normalized net income/share-0.51
Diluted weighted shares outstanding243182.010 M13 M19 M25 M
GeneralAndAdministrativeExpense7 M4 M5 M9 M9 M
Gross operating profit40000.040000.0-415031.0
ImpairmentOfCapitalAssets2 M
Income before tax-12 M-9 M-11 M-20 M-13 M
Income taxes0.0225900.0446351.0-94077.0-502.0
Interest income7392.0-346529.032495.06539.063209.0
InterestExpenseNonOperating1 M
MiscOtherSpecialCharges-3 M2500.046494.0232290.0
Net income from total operations-12 M-9 M-11 M-19 M-13 M
NetIncomeCommonStockholders-12 M-9 M-11 M-19 M-13 M
NetIncomeContinuousOperations-12 M-9 M-11 M-19 M-13 M
NetNonOperatingInterestIncomeExpense-1 M-346529.032495.06539.063209.0
Operating income-7 M-8 M-11 M-18 M-13 M
Operating income before depreciation (EBITDA)-10 M-9 M-11 M-19 M-13 M
OperatingExpense-7 M-8 M-11 M-19 M13 M
Other income net3 M-2500.0235219.0-522000.0
OtherGandA7 M4 M5 M9 M9 M
OtherOperatingExpenses-1 M398600.0
RentAndLandingFees7 M4 M5 M9 M-1400.0
Research & development expense368459.04 M6 M8 M4 M
ResearchExpense368459.04 M6 M8 M4 M
Revenue per share-353236.0-565.0248971.0
SalariesAndWages-5 M-2 M-2 M-4 M416200.0
Selling Gen & administrative expense7 M4 M5 M9 M9 M
Special income/charges-2 M
Total Income available for interest expense (EBIT)-10 M-9 M-11 M-20 M-13 M
Total common shares outstanding10 M17 M24 M29 M
Total net income-12 M-9 M-11 M-19 M-13 M
Total ordinary shares1 M1 M1 M1 M1 M
Total revenues376000.0134969.0
TotalExpenses-7 M-8 M-11 M-19 M-14 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University